Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024

Rhea-AI Summary

Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focusing on obesity and Type 2 Diabetes treatments, has scheduled its third quarter 2024 financial results announcement and business updates for November 12, 2024, at 4:30 p.m. ET. The company will host a live webcast accessible through their investor relations website, with a replay option available after the event.

News Market Reaction – GUTS

+23.19%

+23.19% Session move

In the trading session that priced this news, GUTS gained 23.19%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced it will report financial results for the third quarter 2024 and provide business updates on Tuesday, November 12, 2024, at 4:30 p.m. ET.

A live webcast of the conference call can be accessed in the “Events” section of Fractyl’s website at https://ir.fractyl.com/. The webcast will be archived and available for replay following the live event.

About Fractyl Health        

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com or www.twitter.com/FractylHealth.

Contacts 

Corporate Contact 
Lisa Davidson, Chief Financial Officer 
ir@fractyl.com. 781.902.8800

Media Contact 
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com. 978.760.5622

Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com. 619.949.3681

FAQ

When will Fractyl Health (GUTS) report Q3 2024 earnings?

Fractyl Health will report its third quarter 2024 financial results on Tuesday, November 12, 2024, at 4:30 p.m. ET.

How can I access Fractyl Health's (GUTS) Q3 2024 earnings call?

The earnings call can be accessed through a live webcast in the 'Events' section of Fractyl's website at https://ir.fractyl.com/. A replay will be available after the event.

What is Fractyl Health's (GUTS) main business focus?

Fractyl Health is a metabolic therapeutics company focused on developing new approaches to treat root causes of obesity and Type 2 Diabetes (T2D).